Genes associated with metabolic syndrome predict disease‐free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer
Teodoro Vargas(Madrid Institute for Advanced Studies), Ana Ramı́rez de Molina(Madrid Institute for Advanced Studies), Juan Moreno‐Rubio(Hospital La Paz Institute for Health Research), Paloma Cejas(Dana-Farber Cancer Institute), Cristina Aguayo(Hospital Universitario La Paz), Susana Molina(Madrid Institute for Advanced Studies), Ricardo Ramos(Centre for Plant Biotechnology and Genomics), Jesús Herránz(Madrid Institute for Advanced Studies), Guillermo Reglero(Madrid Institute for Advanced Studies), Ana Custodio(Hospital Universitario La Paz), Jaime Feliú(Hospital Universitario La Paz), Emilio Burgos(Hospital Universitario Infanta Sofía), Margarita González‐Vallinas(Universidad de Valladolid)
Cited by 33
Related Papers
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
|Cancer Discovery|2021|286
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
|Cancer Research|2020|215